iTonic Holdings (ITOC) Change in Accured Expenses (2024 - 2025)

iTonic Holdings recorded quarterly Change in Accured Expenses of $108856.0 in Q2 2025, down 31.51% quarter-over-quarter from $158931.0 in Q4 2024.

iTonic Holdings' Change in Accured Expenses history runs 2 years deep, the most recent figure standing at $108856.0 for Q2 2025.

  • In Q2 2025, Change in Accured Expenses changed N/A year-over-year to $108856.0; the TTM figure through Jun 2025 stood at $108856.0 (changed N/A YoY), while the FY2025 annual figure was $89618.0, down 43.61% from the prior year.
  • Change in Accured Expenses came in at $108856.0 for Q2 2025 at iTonic Holdings, down from $158931.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $158931.0 in Q4 2024 to a low of $108856.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -654.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 703.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -347.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 21.07 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 145.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -250.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 74.30 Mn
10 iTonic Holdings 4.81 Mn 3.89 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 108,856.00
Jun 30, 2025 108,856.00
Dec 31, 2024 158,931.00
Dec 31, 2024 158,931.00